News About: Pharm. Industry
Dong-A to expand production volume of Bacchus-D
Dong-A Pharmaceutical Co. has unveiled its tentative plan to extend its production line of the popular drink Bacchus-D in Dalsung plant in Daegu to give a wider access in supermarkets and 24-hour convenient stores.
...
Multinational and domestic drug makers seeking to cooperate
A closer cooperation between multinational and domestic drug firms is likely to pick up, as they denounce the government’s plan to cut drug prices.
The price-cutting steps, designed to relieve the financial burden ...
Drug makers’ panic is overruling any logical response
The Ministry of Health and Welfare last week announced a set of measures to cut medicine prices, which panicked the domestic pharmaceutical industry.
Pharmaceutical companies said it will wipe out profits, stifle R...
Dong-A, Bayer Korea to strengthen OTC sales and distribution partnership
Dong-A Pharmaceutical said Friday that it has signed an agreement with Bayer Korea to co-market Bayer’s leading eight over-the-counter (OTC) drugs here.
These drugs include Aspirin Protect, oral contraceptives, vit...
Shares of Dong-A, Hanmi boosted by state-led R&D support plan
Shares of research-oriented pharmaceutical firms, such as Dong-A Pharmaceutical firm, Hanmi Pharmaceutical, LG Life Sciences and SK Chemicals, were boosted on Friday by expectations that their new drugs may help lift ...
Lawmaker withdraws for-profit hospital related bill
Rep. Lee Myung-kyu of the ruling Grand National Party said Friday that he asked for the withdrawal of a bill pertaining to the operation of a free economic zone, which includes establishing a for-profit hospital in So...
Multinational drug firms calls for reconsideration of government-led price reduction measures
Retail drug prices are expected to fall about 17 percent on average beginning next year following a set of government-led drug pricing reforms, the government said Friday.
However, multinational drug manufacturers ...
Health ministry to reduce ceilings on prices of generic drugs
The government on Friday announced a set of plans to lower generic drug prices by up to 33 percent starting next year, prompting vehement protests from pharmaceutical firms.
The new measures will bring down the pri...
Green Cross eying sales of 50 billion won with new drug
Green Cross Corp. said Friday it has signed a co-promotion agreement with LG Life Sciences to market “Shinbaro,” a new drug for osteoarthritis in a bid to raise 50 billion won in domestic sales within the next five ye...
Concerns mounting over drug price cut
A new wave of price cuts for drugs is speculated to be imminent here, which has stirred up concerns among domestic drug makers.
The proposed price cut for drugs are said to be a 50-percent level as the Korean gover...
